Freedom is what humans have always desired, cherished and looked forward to. Around the world, over 70 million people require a wheelchair on a daily basis. Another 100 million are dependent on medication or life-saving devices that inhibit their movement or restrict it to a few feet from these devices.
For years, sufferers of COPD have lived a life that was controlled by the time and distance allowed by their oxygen delivery mechanism. As wheelchair-mounted oxygen cylinders would only last for a limited amount of time and stationary oxygen concentrators limited their movement to a single room, these patients would only be able to enjoy their lives for a short duration of time, before being carted back to their room. As medical technology progressed, they put their efforts into addressing the single biggest problem that sufferers of COPD faced on a daily basis – mobility.
Innovation – from the Source
When the founders of Inogen laid the foundation of their company, their single goal was to improve the lives of those suffering from COPD. This improvement was in the form of freedom. The freedom to live life, the way they want to. Inogen pioneered the development of the portable oxygen concentrator that completely changed the lives of those suffering from COPD. With portable oxygen concentrators, patients can now be mobile without needing to lug a heavy oxygen cylinder around with them or being confined to a wheelchair.
The Inogen One G3 system is an FAA approved device, helping patients enjoy vacations as others do. With a battery that lasts over 9 hours, the Inogen One G3 ensures that you can take on those long-haul flights without problems.
Comments